DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
The generic ingredient in KIONEX is sodium polystyrene sulfonate. There are one thousand four hundred and seventy-two drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the sodium polystyrene sulfonate profile page.
Profile for product number 001
|Active Rx/OTC/Discontinued:||RX||Dosage:||POWDER;ORAL, RECTAL||Strength||454GM/BOT|
|Approval Date:||Feb 6, 1998||TE:||AA||RLD:||No|
Complete Access Available with Subscription